bioAffinity Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIAF and other ETFs, options, and stocks.

About BIAF

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. 

CEO
Maria Zannes
CEOMaria Zannes
Employees
57
Employees57
Headquarters
San Antonio, Texas
HeadquartersSan Antonio, Texas
Founded
2014
Founded2014
Employees
57
Employees57

BIAF Key Statistics

Market cap
10.13M
Market cap10.13M
Price-Earnings ratio
-0.18
Price-Earnings ratio-0.18
Dividend yield
Dividend yield
Average volume
39.58M
Average volume39.58M
High today
$2.55
High today$2.55
Low today
$2.11
Low today$2.11
Open price
$2.35
Open price$2.35
Volume
3.52M
Volume3.52M
52 Week high
$46.53
52 Week high$46.53
52 Week low
$0.693
52 Week low$0.693

Stock Snapshot

The current bioAffinity Technologies(BIAF) stock price is $2.25, with a market capitalization of 10.13M. The stock trades at a price-to-earnings (P/E) ratio of -0.18.

During the trading session on 2026-03-18, bioAffinity Technologies(BIAF) shares reached a daily high of $2.55 and a low of $2.11. At a current price of $2.25, the stock is +6.7% higher than the low and still -11.7% under the high.

Trading volume for bioAffinity Technologies(BIAF) stock has reached 3.52M, versus its average volume of 39.58M.

The stock's 52-week range extends from a low of $0.69 to a high of $46.53.

The stock's 52-week range extends from a low of $0.69 to a high of $46.53.

BIAF News

TipRanks 20h
bioAffinity Showcases CyPath Lung Case Study in Diagnostics

bioAffinity Technologies, Inc. ( (BIAF) ) has provided an announcement. bioAffinity Technologies, Inc., a biotechnology company specializing in noninvasive lun...

Benzinga 5d
bioAffinity Technologies Stock Soars 120% On CyPath Lung Sales Growth

bioAffinity Technologies Inc (NASDAQ:BIAF) shares are trading sharply higher Friday morning after the company reported full-year 2025 results highlighting stron...

bioAffinity Technologies Stock Soars 120% On CyPath Lung Sales Growth

People also own

Based on the portfolios of people who own BIAF. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.